文献速递妇产影像腹部MR

MRI影像组学列线图术前预测晚期高级别浆液性卵巢癌小肠系膜粟粒样改变

Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram.
PubMed 文献 · Abdom Radiol (NY) · 2023-01-18

列线图整合影像组学特征、腹水和肿瘤大小,训练队列AUC为0.871(95%CI 0.801-0.941),验证队列AUC为0.858(95%CI 0.739-0.976),较临床模型显著改善分类能力。

要点

  • 术前影像评估MCSBM阴性者仍可能病理阳性,列线图可辅助筛选高危患者。
  • 腹水和肿瘤大小是MCSBM的独立预测因素,阅片时应关注。
  • 列线图预测性能良好,训练和验证队列AUC均高于0.85。

局限性

  • 回顾性研究设计。
  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop and validate an MRI-based radiomics nomogram for the preoperative prediction of miliary changes in the small bowel mesentery (MCSBM) in advanced high-grade serous ovarian cancer (HGSOC).

MATERIALS AND METHODS: One hundred and twenty-eight patients with pathologically proved advanced HGSOC (training cohort: n = 91; validation cohort: n = 37) were retrospectively included. All patients were initially evaluated as MCSBM-negative by preoperative imaging modalities but were finally confirmed by surgery and histopathology (MCSBM-positive: n = 53; MCSBM-negative: n = 75). Five radiomics signatures were built based on the features from multisequence magnetic resonance images. Independent clinicoradiological factors and radiomics-fusion signature were further integrated to construct a radiomics nomogram. The performance of the nomogram was assessed using receiver operating characteristic (ROC) curves, calibration curves and clinical utility.

RESULTS: Radiomics signatures, ascites, and tumor size were independent predictors of MCSBM. A nomogram integrating radiomics features and clinicoradiological factors demonstrated satisfactory predictive performance with areas under the curves (AUCs) of 0.871 (95% CI 0.801-0.941) and 0.858 (95% CI 0.739-0.976) in the training and validation cohorts, respectively. The net reclassification index (NRI) and integrated discrimination improvement (IDI) revealed that the nomogram had a significantly improved ability compared with the clinical model in the training cohort (NRI = 0.343, p = 0.002; IDI = 0.299, p < 0.001) and validation cohort (NRI = 0.409, p = 0.015; IDI = 0.283, p = 0.001).

CONCLUSION: Our proposed nomogram has the potential to serve as a noninvasive tool for the prediction of MCSBM, which is helpful for the individualized assessment of advanced HGSOC patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Guo, Lin, Lu, et al. Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram. Abdom Radiol (NY). 2023. PMID: 36651979. doi:10.1007/s00261-023-03802-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。